ATE420894T1 - Cytokine aus säugetieren, verwandte reagenzien und verfahren - Google Patents

Cytokine aus säugetieren, verwandte reagenzien und verfahren

Info

Publication number
ATE420894T1
ATE420894T1 AT00917821T AT00917821T ATE420894T1 AT E420894 T1 ATE420894 T1 AT E420894T1 AT 00917821 T AT00917821 T AT 00917821T AT 00917821 T AT00917821 T AT 00917821T AT E420894 T1 ATE420894 T1 AT E420894T1
Authority
AT
Austria
Prior art keywords
cytokine
mammal
methods
related reagents
reagents
Prior art date
Application number
AT00917821T
Other languages
German (de)
English (en)
Inventor
Birgit Oppmann
Jacqueline Timans
Robert Kastelein
J Bazan
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE420894T1 publication Critical patent/ATE420894T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00917821T 1999-03-11 2000-03-09 Cytokine aus säugetieren, verwandte reagenzien und verfahren ATE420894T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26790199A 1999-03-11 1999-03-11

Publications (1)

Publication Number Publication Date
ATE420894T1 true ATE420894T1 (de) 2009-01-15

Family

ID=23020618

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00917821T ATE420894T1 (de) 1999-03-11 2000-03-09 Cytokine aus säugetieren, verwandte reagenzien und verfahren

Country Status (9)

Country Link
EP (2) EP1159299B1 (enExample)
JP (1) JP2003500010A (enExample)
AR (1) AR022890A1 (enExample)
AT (1) ATE420894T1 (enExample)
AU (1) AU3873200A (enExample)
CA (1) CA2366706A1 (enExample)
DE (1) DE60041393D1 (enExample)
ES (1) ES2319958T3 (enExample)
WO (1) WO2000053631A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2804435A1 (fr) * 2000-01-27 2001-08-03 Pf Medicament COMPLEXE ISOLE COMPRENANT UNE PROTEINE NNT-1 ET EN OUTRE AU MOINS UNE PROTEINE CLF-1 ET/OU UNE PROTEINE sCNTFRalpha
US7045283B2 (en) * 2000-10-18 2006-05-16 The Regents Of The University Of California Methods of high-throughput screening for internalizing antibodies
CA2525184C (en) 2003-05-09 2012-10-30 Centocor, Inc. Il-23p40 specific immunoglobulin derived proteins, compositions, methods and uses
AR051444A1 (es) 2004-09-24 2007-01-17 Centocor Inc Proteinas derivadas de inmunoglobulina especifica de il-23p40, composiciones, epitopos, metodos y usos
HRP20130400T1 (en) 2005-06-30 2013-06-30 Janssen Biotech, Inc. Anti-il-23 antibodies, compositions, methods and uses
DK1931710T3 (en) 2005-08-31 2017-04-03 Merck Sharp & Dohme CONSTRUCTED ANTI-IL-23 ANTIBODIES
DK2548577T3 (en) 2005-12-29 2017-03-13 Janssen Biotech Inc HUMAN ANTI-IL-23 ANTIBODIES, COMPOSITIONS, PROCEDURES AND APPLICATIONS
US8293883B2 (en) 2007-02-23 2012-10-23 Schering Corporation Engineered anti-IL-23P19 antibodies
SG178804A1 (en) 2007-02-23 2012-03-29 Schering Corp Engineered anti-il-23p19 antibodies
NZ579251A (en) 2007-02-28 2012-06-29 Schering Corp Engineered anti-il-23r antibodies
US20100135998A1 (en) 2007-02-28 2010-06-03 Schering Corporation Combination therapy for treatment of immune disorders
WO2014004436A2 (en) 2012-06-27 2014-01-03 Merck Sharp & Dohme Corp. Crystalline anti-human il-23 antibodies
UA117466C2 (uk) 2012-12-13 2018-08-10 Мерк Шарп Енд Доме Корп. СТАБІЛЬНИЙ СКЛАД У ВИГЛЯДІ РОЗЧИНУ АНТИТІЛА ДО IL-23p19
CA3060581A1 (en) 2017-05-02 2018-11-08 Merck Sharp & Dohme Corp. Formulations of anti-lag3 antibodies and co-formulations of anti-lag3 antibodies and anti-pd-1 antibodies
JOP20190260A1 (ar) 2017-05-02 2019-10-31 Merck Sharp & Dohme صيغ ثابتة لأجسام مضادة لمستقبل الموت المبرمج 1 (pd-1) وطرق استخدامها
MX2021005394A (es) 2018-11-07 2021-07-06 Merck Sharp & Dohme Llc Co-formulaciones de anticuerpos anti-gen de activacion de linfocitos 3 (anti-lag3) y anticuerpos anti-muerte programada-1 (anti-pd-1).
MA55149A (fr) 2018-11-20 2021-09-29 Janssen Biotech Inc Procédé sûr et efficace de traitement du psoriasis avec un anticorps spécifique anti-il-23
AU2020279987A1 (en) 2019-05-23 2021-11-18 Janssen Biotech, Inc. Method of treating inflammatory bowel disease with a combination therapy of antibodies to IL-23 and TNF alpha
CA3183927A1 (en) 2020-05-21 2021-11-25 Janssen Biotech, Inc. Method of treating inflammatory bowel disease with a combination therapy of antibodies to il-23 and tnf alpha

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3940475A (en) 1970-06-11 1976-02-24 Biological Developments, Inc. Radioimmune method of assaying quantitatively for a hapten
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
DE3382317D1 (de) 1982-03-15 1991-07-25 Schering Corp Hybride dns, damit hergestellte bindungszusammensetzung und verfahren dafuer.
US4659678A (en) 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4859609A (en) 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
US5470952A (en) * 1993-10-20 1995-11-28 Regeneron Pharmaceuticals, Inc. CNTF and IL-6 antagonists
EP1950226A3 (en) * 1995-08-01 2010-08-11 F. Hoffmann-La Roche AG An antibody against a receptor for human interleukin - 12 and its use
AUPO224696A0 (en) * 1996-09-11 1996-10-03 Amrad Operations Pty. Limited A novel haemopoietin receptor and genetic sequences encoding same
EP1005552A1 (en) * 1997-01-16 2000-06-07 Genetics Institute, Inc. Member of the hematopoietin receptor superfamily
US5741772A (en) * 1997-02-03 1998-04-21 Amgen Inc. Neurotrophic factor NNT-1
DE69825580T2 (de) * 1997-02-03 2005-09-29 Amgen Inc., Thousand Oaks Neurotrophischer faktor nnt-1
WO1998049307A1 (en) * 1997-05-01 1998-11-05 Zymogenetics, Inc. Mammalian cytokine-like receptor
AU8165298A (en) * 1997-06-30 1999-01-19 Human Genome Sciences, Inc. Cardiotrophin-like cytokine
GB9721961D0 (en) * 1997-10-16 1997-12-17 Glaxo Group Ltd Novel molecules
KR100386046B1 (ko) * 1997-12-03 2003-06-02 제넨테크, 인크. 폴리펩티드 및 이를 암호화하는 핵산
WO1999035264A1 (en) * 1998-01-09 1999-07-15 Immunex Corporation H14 dna and polypeptides
AU2661199A (en) * 1998-02-06 1999-08-23 Schering Corporation Mammalian receptor proteins; related reagents and methods
DE60041697D1 (de) * 1999-06-01 2009-04-16 Schering Corp Säugetier-rezeptorproteine; ähnliche reagentien und methoden
FR2804435A1 (fr) * 2000-01-27 2001-08-03 Pf Medicament COMPLEXE ISOLE COMPRENANT UNE PROTEINE NNT-1 ET EN OUTRE AU MOINS UNE PROTEINE CLF-1 ET/OU UNE PROTEINE sCNTFRalpha

Also Published As

Publication number Publication date
EP1942114A2 (en) 2008-07-09
AU3873200A (en) 2000-09-28
ES2319958T3 (es) 2009-05-18
AR022890A1 (es) 2002-09-04
WO2000053631A1 (en) 2000-09-14
CA2366706A1 (en) 2000-09-14
EP1159299B1 (en) 2009-01-14
EP1942114A3 (en) 2008-08-27
JP2003500010A (ja) 2003-01-07
DE60041393D1 (de) 2009-03-05
EP1159299A1 (en) 2001-12-05

Similar Documents

Publication Publication Date Title
ATE420894T1 (de) Cytokine aus säugetieren, verwandte reagenzien und verfahren
DE60036746D1 (de) Analysator
DE60140895D1 (de) Zusammensetzung und verfahren
DE69930964D1 (de) Zusammensetzungen und verfahren für mukosale abgabe
DE60125437D1 (de) Mehrwegedetektor und zugehöriges Verfahren
DE60045610D1 (de) Routenauswahlverfahren und -Gerät
ATE276035T1 (de) Verfahren zur selektiven reduktion von stickoxiden
DE60135637D1 (de) Datenverteilungssystem und verfahren
NO20023746D0 (no) Optimisert samplesystem
FI991134L (fi) Ohjelmiston testaus
DE50213327D1 (de) Anbaueinrichtung, Fahrzeug und Verfahren
DE60144464D1 (de) Probenentnehmer
DE60122160D1 (de) Antennenstruktur und zugehöriges verfahren
DE60116076D1 (de) Scherfluidisierende schreibzusammensetzungen, schreibgeräte und verfahren
DE60106372D1 (de) Redox System und Verfahren
DE60134283D1 (de) Dokumentzuführvorrichtung und Verfahren
DE69939280D1 (de) Sende-Empfänger und Verfahren
ATE275183T1 (de) Fischer-tropsch verfahren
EP1455841A4 (en) COMPOSITIONS AND METHODS RELATED TO OSTEOPONTIN
DE60122651D1 (de) Fahrzeugaufhängungsvorrichtung
ID29888A (id) Metode penanganan copd
DE60122320D1 (de) Rake sythesierungsanordnung und verfahren
DE50107033D1 (de) Standardinterface für Fahrzeuge
EP1416945A4 (en) IMPROVED HETEROPOLYMER COMPLEXES AND METHODS FOR THEIR USE
DE50003545D1 (de) Verfahren zur entschwefelung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties